- Condition: Factory New
- Warranty: Not Available
- Weight: 4.18 lb
-
Learn more:
-
MFR:
B. Braun
Ships from MFI Medical
-
MPN: 3123-11
- Phone: (800) 227-2862
Frequently asked questions
Does the B. Braun Cefoxitin Duplex Container contain latex?
No, the components of the B. Braun Cefoxitin Duplex Container do not contain natural rubber latex, making it safe for patients with latex sensitivities.
How many containers are included per case?
Each case of the B. Braun Cefoxitin Duplex Container includes 24 individual units. The product is packaged this way to be economical and help reduce drug waste in clinical settings.
Does the B. Braun Cefoxitin Duplex Container meet safety guidelines?
Yes, the B. Braun Cefoxitin Duplex Container meets Joint Commission and USP 797 guidelines, and it is constructed without latex, PVC, or DEHP.
Does the Duplex Container reduce medication errors?
Yes, the B. Braun Duplex Container is engineered as a ready-to-use IV system to maximize patient safety and significantly reduce the potential for errors.
Key features that contribute to this enhanced safety include:
- Pre-filled, Accurate Doses: The system eliminates manual compounding errors by containing pre-measured, accurate doses of both the drug and the diluent.
- Built-in Safety Mechanism: The two-compartment design ensures that the diluent cannot be delivered without the active medication being mixed, reducing the risk of accidental delivery of an unmedicated solution.
- Closed System Integrity: The sealed, closed system protects the medication’s potency and prevents external contamination.
- Compliance and Automation: The system meets strict standards, including Joint Commission and USP 797 guidelines, and facilitates accurate tracking through barcoding compatible with automated dispensing systems.
What drug dosing strengths are available?
The B. Braun Cefoxitin Duplex Container system is available in two pre-measured dosage strengths, both yielding a final delivery volume of 50 mL:
- 1 Gram
- 2 Grams
These ready-to-use containers are designed with pre-filled, accurate doses of both the drug and diluent, which helps reduce or eliminate mixing errors. They are packaged and sold in cases containing 24 units.
What is the total shelf life?
The total shelf life for the B. Braun Cefoxitin Duplex Container is 18 months. This allows for stable storage at room temperature, eliminating the need for thawing prior to administration.
Is the B. Braun Cefoxitin Duplex Container ready to use upon arrival?
Yes, the B. Braun Cefoxitin Duplex Container is ready-to-use, pre-filled with accurate drug and diluent doses, simplifying the administration process.
Can the Cefoxitin Duplex container be stored at room temperature?
Yes, this system is specifically designed for clinical convenience, featuring a ready-to-use IV system that does not require freezing or thawing and can be stored safely at room temperature.
Additional storage benefits include:
- Shelf Life: The product offers a total shelf life of 18 months.
- System Integrity: The closed, two-compartment design ensures medication safety, preventing contamination and actively protecting drug potency until the moment of use.
What is the container's standard delivery size?
The standard delivery size for this ready-to-use duplex container is 50 mL.
This fixed volume applies to both the 1 Gram and 2 Gram drug dosage options, ensuring precise, pre-measured mixing of the Cefoxitin drug and Dextrose diluent immediately prior to administration.
Is the Duplex container a contamination-proof closed system?
Yes, the B. Braun Cefoxitin Duplex Container is engineered as an advanced closed system to ensure maximum sterility and drug integrity.
This closed design offers several key benefits:
- Contamination Prevention: It maintains a sealed environment to prevent external contamination and safeguard the drug’s potency until mixing.
- Staff Safety: It enhances safety protocols by protecting staff from exposure to airborne cephalosporins.
- Regulatory Compliance: The system meets rigorous standards for quality and safety, including USP 797 guidelines.